Suboxone at First Clinic Visit: Eligibility, Policies & What to Expect

Whether a clinic prescribes buprenorphine/naloxone (Suboxone) at a first visit depends on federal regulations, state laws, and clinic-specific protocols.

Federal Requirements (DATA 2000 / MAT Act 2023)

  • Prescriber must have DEA registration with Schedule III authority (X-waiver eliminated 2023)
  • Patient must meet DSM-5 criteria for Opioid Use Disorder (OUD)
  • Informed consent, treatment agreement, diversion control plan

Typical First-Visit Steps

  1. Intake assessment: History, physical, drug screen, COWS (Clinical Opiate Withdrawal Scale) score
  2. Diagnosis confirmation: OUD moderate/severe
  3. Induction readiness: In mild-moderate withdrawal (COWS ≥8–12) to avoid precipitated withdrawal
  4. First dose: Observed in office (2–4 mg SL); reassess 1–2 hrs; may give additional 2–4 mg
  5. Prescription: Usually 1–2 weeks; frequent follow-ups initially

Clinic Policy Variables

  • Prior treatment: Some require transfer paperwork from previous prescriber
  • Detox requirement: Rare now; most use buprenorphine for induction directly
  • Counseling mandate: Many require concurrent behavioral health
  • Drug screening: Baseline + random; some require negative for other opioids
  • Pregnancy: Buprenorphine monoproduct preferred; specialized prenatal coordination

If You Already Have Buprenorphine in Your System

Clinic may: continue same dose, adjust, or require stabilization period. Honest disclosure is essential—precipitated withdrawal risk if full agonist still on receptors.

Call ahead: ask about intake process, required documents, induction protocol, counseling requirements, cost/insurance.

Prescription Medications - Related Articles